Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWALG.L Regulatory News (WALG)

  • There is currently no data for WALG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Update

27 Mar 2020 08:31

Walcom Group Ltd - Company Update

Walcom Group Ltd - Company Update

PR Newswire

London, March 27

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

27 March 2020

WALCOM GROUP LIMITED(“Walcom” or “the Company”)

Company update and further re director loan

Further to the announcement on 18 March 2020, the Board of Walcom provides an update on the Company’s working capital position. Regrettably, Mr Francis Chi, Chief Executive of the Company, has been unable to provide the proposed loan of HK$1,230,000 (the “Director Loan”) to Walcom Bio-Chemicals Industrial Limited, Walcom’s wholly owned subsidiary, as intended. Mr Chi has reiterated his intention to provide the Director Loan.

The Company continues to receive and process customer orders. In addition, the management have sought to defer expenses, where possible, without affecting the normal operations of the Company.

The Company is due to make a partial repayment of a bank loan, amounting to RMB150k, by the end of March 2020. Whilst the Company has sufficient funds to make this repayment, the management are in discussions with the bank to seek to reduce the quantum to be repaid.

Irrespective of the outcome of these discussions, in the absence of the Director Loan being received in part or in full by 3 April 2020, the Company may be unable to continue its operations and would be forced into liquidation with a consequential diminution in value to shareholders.

Further announcements will be made in due course. 

Further enquiries:

Walcom Group Limited Francis Chi (Chief Executive Officer/Chief Financial Officer) +852 2494 0133
Allenby Capital Limited (Nominated Adviser and broker) David Hart / Asha Chotai+44 20 3328 5656
Date   Source Headline
16th Jul 200811:08 amPRNDirector/PDMR Shareholding
30th Jun 20087:00 amPRNAcquisition of Beijing New World Bio-technology Company
1st May 200812:14 pmPRNFinal Results
30th Apr 20084:34 pmPRNAcquisition(s)
18th Mar 20081:03 pmPRNChange of Broker
6th Sep 200710:38 amPRNHalf-yearly Report
15th Aug 20079:07 amPRNAIM Rule 26 Announcement
31st May 200712:03 pmPRNResignation of Senior Manager
27th Apr 20079:01 amPRNFinal Results
2nd Apr 20079:02 amPRNPatent Assignment
21st Dec 20069:00 amPRNFirst day dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.